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Background: Biological effects of tailor-made multi-walled carbon nanotubes (MWCNTs) without functionalization
were investigated in vivo in a two-year carcinogenicity study. In the past, intraperitoneal carcinogenicity studies in
rats using biopersistent granular dusts had always been negative, whereas a number of such studies with different
asbestos fibers had shown tumor induction. The aim of this study was to identify possible carcinogenic effects of
MWCNTs. We compared induced tumors with asbestos-induced mesotheliomas and evaluated their relevance for
humans by immunohistochemical methods.
Methods: A total of 500 male Wistar rats (50 per group) were treated once by intraperitoneal injection with 109 or
5 × 109 WHO carbon nanotubes of one of four different MWCNTs suspended in artificial lung medium, which was
also used as negative control. Amosite asbestos (108 WHO fibers) served as positive control. Morbid rats were
sacrificed and necropsy comprising all organs was performed. Histopathological classification of tumors and,
additionally, immunohistochemistry were conducted for podoplanin, pan-cytokeratin, and vimentin to compare
induced tumors with malignant mesotheliomas occurring in humans.
Results: Treatments induced tumors in all dose groups, but incidences and times to tumor differed between
groups. Most tumors were histologically and immunohistochemically classified as malignant mesotheliomas,
revealing a predominantly superficial spread on the serosal surface of the abdominal cavity. Furthermore, most
tumors showed invasion of peritoneal organs, especially the diaphragm. All tested MWCNT types caused
mesotheliomas. We observed highest frequencies and earliest appearances after treatment with the rather straight
MWCNT types A and B. In the MWCNT C groups, first appearances of morbid mesothelioma-bearing rats were only
slightly later. Later during the two-year study, we found mesotheliomas also in rats treated with MWCNT D – the
most curved type of nanotubes. Malignant mesotheliomas induced by intraperitoneal injection of different MWCNTs
and of asbestos were histopathologically and immunohistochemically similar, also compared with mesotheliomas in
man, suggesting similar pathogenesis.
Conclusion: We showed a carcinogenic effect for all tested MWCNTs. Besides aspect ratio, curvature seems to be
an important parameter influencing the carcinogenicity of MWCNTs.
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Discussions about the hazardous potential of CNTs began
very early, with regard to possible toxic and carcinogenic
effects well known from persistent natural and man-made
mineral fibers. CNTs came under suspicion, because the
generally accepted prerequisites for a mineral fiber to be
able to exert a carcinogenic effect in the lung and pleura
can also be found in some CNTs. These prerequisites
include: low solubility, long alveolar macrophage clearance
half-time, a fiber length of at least 5 μm and a fiber diam-
eter of less than 3 μm with an aspect ratio (ratio of fiber
length to fiber diameter) of at least 3:1. Fibers fulfilling
these criteria fall under the definition of the so-called
“WHO fibers” [1]. Experimental animal studies have also
shown that the toxic and carcinogenic potency of mineral
fibers increases with growing fiber length [2]. Fibers longer
than 15 to 20 μm exerted stronger toxic and carcinogenic
effects than shorter ones, because alveolar macrophages
are unable to completely take up such longer fibers [3].
Epidemiological studies and also investigations in experi-
mental animals have proven the toxic and carcinogenic
effects of natural mineral fibers such as asbestos [4,5].
Fiber-specific tumors are mesotheliomas of the pleura, but
lung tumors are caused as well. Man-made mineral fibers
(MMMF) displaying low solubility, high biopersistence,
and fulfilling the WHO fiber definition caused lung tumors
and mesotheliomas in experimental animals in a way very
similar to asbestos fibers [6].
Proving or disproving the carcinogenic potential of min-
eral fibers in experimental animals after inhalation exposure
is very costly and there are only few laboratories worldwide
that are able to adequately conduct such inhalation studies
with fiber dusts. Therefore, another test was developed and
accepted by the regulatory authorities in the EU to investi-
gate whether newly developed mineral fibers have a poten-
tial to induce tumors originating from the epithelial cells of
the pleura or peritoneum [7]. For this test, a suspension of
a certain number concentration of WHO fibers of the min-
eral fiber under evaluation is injected once into the periton-
eum of rats, and the animals thus treated have to be kept
for two years and investigated histopathologically for meso-
theliomas. The number of WHO fibers that have to be ap-
plied according to the regulatory authorities is 109 and in a
more rigorous test approach can be increased to 5 × 109. As-
bestos fibers that caused mesotheliomas in humans as well
as asbestos fibers and man-made mineral fibers that caused
mesotheliomas in experimental animals after inhalation ex-
posure also caused mesotheliomas after intraperitoneal (i.p.)
injection in rats [8]. This test in rats is specific for biopersis-
tent fibers; biopersistent granular dusts, in contrast, are not
able to induce mesotheliomas in this test system, even when
administered at very high doses (4 × 20 mg per rat i.p.) [9].
CNTs can be produced as single- or multi-walled tubes.
Diameters of single-walled carbon nanotubes (SWCNTs)are generally below 10 nm, whereas those of MWCNTs
are mostly above 20 nm up to 150 nm [10,11]. In the
present study, we investigated only MWCNTs. SWCNTs
and also MWCNTs can be very long, reaching dimensions
comparable to long mineral fibers, and CNTs are almost
insoluble because of their inorganic carbon structure. This
means that some MWCNTs also meet the prerequisites
for causing fiber-specific toxic effects.
Early pathological effects observed after short-time
intraperitoneal administration of CNTs in mice were
very similar to effects observed with asbestos fibers [12].
Takagi and co-workers [13] found mesotheliomas in
p53-heterozygous mice after intraperitoneal injection of
CNTs and asbestos fibers, whereas a different study
revealed no tumors in rats after i.p. injection of CNTs
shorter than 1 μm [14]. In another study in rats, mesothe-
liomas were found after i.p. injection of MWCNTs with
an average length of 4 to 5 μm [15].
In the present study, we also used the i.p. carcinogenicity
test in rats to investigate whether four specially designed
MWCNTs of different lengths, diameters, and curvatures
have the potential to induce mesotheliomas similarly to
asbestos fibers. We tested each of the four CNTs used with
WHO dimensions at two CNT number concentrations
according to the recommendation for the carcinogenicity
test with mineral fibers. Fifty male rats were treated in each
dose group. The negative control group was treated with
suspension medium only and the positive control group
with amosite asbestos at a ten-fold lower fiber number. We
chose the number concentration used for i.p. administra-
tion of amosite asbestos based on published data showing
that 1 × 108 WHO amosite asbestos fibers will induce about
50% mesothelioma-bearing rats after two years of experi-
mental time [16].
Besides the number and percentage of MWCNTs with
WHO dimensions, we also determined the percentage of
MWCNTs longer than 20 μm per injected suspension.
For suspension of the nanotubes and also for the negative
control group, we used the fluid according to Porter and
co-workers [17] so as to prevent aggregation of nanotubes.
Due to the content of 1,2-dipalmitoyl-sn-glycero-3-phos-
phocholine this fluid has similarities to surfactant.
Experimental animals were killed when morbid or after two
years of experimental time. We performed histopathological
examination and determined the numbers of animals with
mesotheliomas per experimental group. In addition, we con-
ducted immunohistochemical investigations of the tumor
tissue in respect of some markers specific for mesothelioma.
Furthermore, we also recorded body weight and mortality.
The tumors induced by intrapleural or intraperitoneal
injection of asbestos fibers in rats were classified as malig-
nant mesotheliomas [18,19] closely resembling human
malignant mesothelioma in their biological behavior and
histopathology. Human malignant mesotheliomas have
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growth patterns [20,21]. The same categories have been
specified for rat mesotheliomas [22]. For mesotheliomas in
humans, a variety of immunohistochemical antigens have
been described. Key features seem to be the occurrence of
vimentin in the majority of mesotheliomas [23,24], a
marker for mesenchymal cells and mesothelium, wide-
spectrum cytokeratin [25-27] as a marker for epithelial cells
and mesothelium, and positivity for podoplanin [28-31],
which is a marker for lymphatic endothelium. These
markers were also observed in mesotheliomas of rats [32].
In the present study, the tumor material was investi-
gated histopathologically and immunohistochemically for
the three markers cytokeratin, vimentin, and podoplanin.
All MWCNTs tested in this study showed a strong
carcinogenic effect. Besides the diameter and length of
MWCNTs, curvature seems to have had an influence on
carcinogenic potency.Results
Mortality
In the MWCNT A and B low- and high-dose groups
and in the MWCNT C high-dose group, 80% of the ani-
mals died or were humanely killed due to a bad clinical
condition (for mortality curves see Figure 1). In the
MWCNT C low-dose group, mortality reached 80%
16 months after the intraperitoneal treatment. The
MWCNT D high-dose group showed 80% mortality
after 23 months. At the end of the experimental time
after 24 months, mortality was 56% in the MWCNT D
low-dose group, 76% in the amosite asbestos group, and
34% in the negative control group.Figure 1 Mortality curves in % of all rats of the study comprising all a
condition. A group was terminated when 80% mortality was reached.Macroscopic findings
At necropsy most animals of the MWCNT treatment
groups and the majority of rats of the amosite asbestos
group revealed ascites consisting of blood-containing
fluid. Most animals showed adhesions and multifocal to
coalescing small nodular lesions on the surface of the
abdominal organs. Many rats had large nodules or tissue
masses especially in the area of the diaphragm, liver, and
pancreas, but the small intestine was also frequently in-
volved. In some animals, we found aggregates of foreign
material covered by a thin layer of serosa, primarily at
the diaphragm and liver. The liver and spleen capsules
were thickened and firm in numerous rats.
Histopathological findings
Tumor incidences and time dependence
The most frequent tumors in the MWCNT and amosite
asbestos treatment groups were malignant mesotheliomas
of the peritoneum. In most cases these tumors were the
obvious reason for a morbid condition of the rats and trig-
gered the decision to perform euthanasia. In addition, we
found a few pancreatic islet-cell adenomas, Leydig cell
adenomas of the testes, and one renal lipoma. Tumors in
other organs were infrequently and their incidences corre-
sponded to normal spontaneous background.
Table 1 shows the incidences of malignant mesothelio-
mas including survival times of mesothelioma-bearing
rats. The development of malignant mesotheliomas over
time is shown in Figure 2.
Rats in the MWCNT A groups developed a mesotheli-
oma rate of 98% in the high-dose group and of 90% in
the low-dose group. Mesothelioma-bearing animals had
a mean survival time of 194 days in the high-dose groupnimals which died or were humanely killed due to a bad clinical
Table 1 Incidences of malignant mesotheliomas, mean survival times of morbid mesothelioma-bearing rats, and first day of mesothelioma detection
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Medium control - - - 50 1 (2%) 739 24 24
MWCNT A low 8.57 ± 1.51 0.085 ± 1.60 0.48 50 49 (98%) 213 5 9
MWCNT A high 2.39 50 45 (90%) 194 5 8
MWCNT B low 9.30 ± 1.63 0.062 ± 1.71 0.96 50 46 (92%) 294 6 13
MWCNT B high 4.80 50 45 (90%) 207 5 9
MWCNT C low 10.24 ± 1.64 0.040 ± 1.57 0.87 50 42 (84%) 415 10 18
MWCNT C high 4.36 50 47 (94%) 265 6 11
MWCNT D low 7.91 ± 1.40 0.037 ± 1.45 1.51 50 20 (40%) 666 20 24
MWCNT D high 7.54 50 35 (70%) 585 11 24
Long amosite
asbestos
13.95 ± 2.10 0.394 ± 1.83 0.14 50 33 (66%) 623 14 24
*WHO fibers: length greater than 5 μm, diameter less than 3 μm, and a length-to-width ratio (aspect ratio) of at least 3:1.
##Actual WHO fiber number dose; deviations from target values are due to inhomogeneities during successive synthesis or suspension of test items.

















Figure 2 Animals with malignant mesotheliomas over time in %. A group was terminated when 80% mortality was reached.
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were detected in rats euthanized between 5 and 9 months
in the low-dose group and between 5 and 8 months in
the high-dose group.
In the MWCNT B groups, we found mesothelioma
rates of 90% (high dose) and 92% (low dose). Survival
times of mesothelioma-bearing rats were 207 days (high
dose) and 294 days (low dose). Mesothelioma-bearing
rats were euthanized between 5 and 12 months in the
low-dose group and between 5 and 9 months in the
high-dose group.
Incidences of mesotheliomas in the MWCNT C
groups were 94% after treatment with the high dose and
84% with the low dose. In these groups, mesothelioma-
bearing rats had a mean survival time of 265 days with
the high dose and of 415 days with the low dose. Ani-
mals with mesotheliomas were observed between 10 and
18 months after treatment in the low-dose group and
between 5 and 10 months after treatment in the high-
dose group.
Animals of the MWCNT D treatment groups developed
malignant mesotheliomas in 70% (high dose) and 40%
(low dose). Survival times of the mesothelioma-bearing
rats were 585 days with the high dose and 666 days with
the low dose. We detected mesotheliomas in rats eutha-
nized between 20 and 24 months in the low-dose group
and between 11 and 24 months in the high-dose group.
In the amosite asbestos group, the mesothelioma inci-
dence was 66%, with a mean survival time of 623 days. We
observed mesotheliomas in rats euthanized between 14 and
24 months after intraperitoneal injection.
In the rats of the medium control group, we found
one mesothelioma (2%) during final necropsies.Other non-neoplastic MWCNT-induced histopathological
findings in the abdominal cavity
Most of the MWCNT-treated rats showed multiple
granulomas on the peritoneal surface of the abdominal
organs and diaphragm. The granulomas frequently consisted
of a central hyaline area which mostly included a few single
fibers, surrounded by macrophages and lymphocytes. An
outer layer of fibrocytes and collagen, covered by serosa, was
mostly visible (see Figure 3). Organs such as the liver and
spleen were engulfed by a thick layer of collagen-rich con-
nective tissue intermingled with granulomas. In many cases,
the liver showed adhesions to the diaphragm by fibrotic if
not tumor tissue. We found agglomerates of foreign material
underneath the serosa in many animals. Multifocal papillary
projections of mesothelial hyperplasia were observed espe-
cially on the diaphragm and diaphragmatic liver surface.
Large aggregates occurred infrequently, whereas we
observed single nanotubes in every slide (see Figure 3).
Similar lesions were found in asbestos-treated animals
(see Figure 3).
Histologic appearance of malignant mesotheliomas
Malignant mesotheliomas showed predominantly superfi-
cial growth on the serosal surface of the peritoneum of the
liver, spleen, intestine, and abdominal wall. We frequently
observed invasion into the mesentery, pancreatic tissue,
and diaphragm. All in all, 320 of the 329 MWCNT-related
malignant mesotheliomas had invaded the diaphragm, and
174 of these tumors showed invasion of the thoracic cavity.
In the amosite asbestos group, which displayed 33 (66%)
mesotheliomas, 29 mesotheliomas had invaded the dia-
phragm, and 5 of these tumors showed invasion of the
thoracic cavity.
Figure 4 Histological typing of malignant mesotheliomas
occurring in the study. The most frequent type of mesothelioma
was the sarcomatoid type, followed by mesotheliomas of the
biphasic type. Mesotheliomas of the epithelioid type were rare.
Figure 3 Non-neoplastic histopathological findings in the abdominal cavity. A: High-power view of anti-podoplanin immunohistochemistry
showing single MWCNT A (high dose) nanotubes in the tissue (arrows). B: High-power view of anti-podoplanin immunohistochemistry showing
single asbestos fibers in the tissue (arrows). C: H & E, high-power view of granuloma induced by MWCNT A (low dose) nanotubes including single
nanotube (arrow, 25×). D: H & E, high-power view of granuloma induced by asbestos including single fiber (arrow, 40×).
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sulated, but it was frequently invaded as well. In contrast,
invasion of the spleen along the vascular blood supply was
rare. All malignant mesotheliomas showed some cellular
pleomorphism; some of the tumors exhibited partly ana-
plastic round cells, especially those occurring early in the
study. A couple of mesotheliomas developed areas with
mucus production, others showed microcystic areas.
Based on their appearance in the H & E stain, we differen-
tiated the malignant mesotheliomas into epithelioid, sarco-
matoid, and biphasic types (see Figure 4). Malignant
mesotheliomas of the epithelioid type occurred occasionally
in the MWCNT groups B high, C low and high, D low and
high, and in the amosite asbestos group. The malignant
mesothelioma found in the medium control group displayed
an epithelioid appearance. Epithelioid-type malignant meso-
theliomas showed papillary structures or poorly formed
glandular structures and round nuclei, and they infiltrated
the adjacent connective tissue. All epithelioid-type malignant
mesotheliomas were immunohistochemically positive for the
markers pan-cytokeratin, podoplanin, and vimentin.Malignant mesotheliomas of the sarcomatoid type (see
Figure 5) were frequent in all MWCNT and amosite asbes-
tos groups. The sarcomatoid-type mesotheliomas consisted
of spindle-shaped cells with elongated nuclei forming bun-
dles or whorls of cells. We observed osseous differentiation
in a number of cases in each group. All sarcomatoid-type
Figure 5 Sarcomatoid-type malignant mesothelioma observed in the MWCNT B high-dose group. A: H & E, low magnification of tumor
tissue invading the diaphragm (20×). B and C: H & E, high-power view (40×). D: High-power view of anti-vimentin immunohistochemistry
showing a strongly positive result (40×). E: High-power view of anti-pan-cytokeratin immunohistochemistry showing several positive cells (40×).
F: High-power view of anti-podoplanin immunohistochemistry revealing positively stained cytoplasm of many cells (40×).
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positive for the markers vimentin and podoplanin.
Malignant mesotheliomas of the biphasic type, compris-
ing both epithelioid and sarcomatoid patterns, were also
seen in animals of all MWCNT groups (see Figure 6) and
the amosite asbestos group (see Figure 7). Several of these
tumors exhibited osseous differentiation in parts of the
lesion. All biphasic-type malignant mesotheliomas were
immunohistochemically positive for the markers vimentin,
podoplanin, and pan-cytokeratin.
Mesotheliomas occurring in the early phase of the study
more frequently showed a higher number of poorly differen-
tiated cells or areas of anaplastic cells.
Malignant mesotheliomas in the amosite asbestos group
developed the same histological appearances and reactions
to immunohistological markers as the MWCNT-induced
mesotheliomas.
Overall, the study revealed highest incidences for the
sarcomatoid type of mesothelioma, followed by the biphasictype. Mesotheliomas of the epithelioid type were rare in
our study.
Discussion
The hypothesis of a mesothelioma-inducing potential of
multi-walled carbon nanotubes, assumed because of their
fiber-like dimensions and biopersistence comparable to
asbestos fibers, was confirmed by our experimental investi-
gations with rats treated intraperitoneally with tailor-made
MWCNTs which were suspended in fluid according to Por-
ter and co-workers [17] similar to surfactant-containing
lung fluid. Amosite asbestos fibers served as positive con-
trol. A dose-dependent difference in the carcinogenic
response, however, is difficult to deduce from our study.
Tumor incidences in all MWCNT dose groups treated with
109 or 5 × 109 nanotubes were 40 to 100%. Our experimen-
tal results thus clearly provide proof of the mesothelioma-
inducing potential of these MWCNTs in rats. However, the
data cannot be used for risk assessment. This is especially
Figure 6 Biphasic-type malignant mesothelioma observed in the MWCNT D low-dose group. A: H & E, low magnification of tumor tissue
found on the surface of the omentum (20×). B and C: H & E, high-power view (40×). D: High-power view of anti-vimentin immunohistochemistry
showing a strongly positive result (40×). E: High-power view of anti-pan-cytokeratin immunohistochemistry showing positive staining of the
majority of cells (40×). F: High-power view of anti-podoplanin immunohistochemistry revealing positively stained cytoplasm of many cells (40×).
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of MWCNTs in rats after inhalation exposure and in par-
ticular also no information on the exposure concentration
needed to reach a sufficient dose of MWCNTs at the pleura
to induce mesotheliomas.
As positive control, we injected a long type of amosite
asbestos, dosed at a concentration of 1 × 108 WHO fibers
per animal. Using this dose, a mesothelioma incidence of ap-
proximately 50% could be expected. Davis and co-workers
[16], who investigated the UICC standard reference of amos-
ite asbestos, reported the following data: At doses of 0.5,
2.5 mg, and 15 mg amosite, corresponding to 1.7 × 107,
8.5 × 107, and 5.1 × 108 fibers with a length greater than
5 μm, respectively, they found mesothelioma incidences of
46.9%, 59.4%, and 79.2%. At a dose of 1 × 108 fibers greater
than 5 μm, a mesothelioma incidence of approximately 50%
can be predicted [16]. In the present study, the incidence of
mesotheliomas caused by asbestos was 66%.There are various hypotheses on the mechanisms that
might contribute to the induction of tumors by biopersis-
tent fibrous particles. The carcinogenic effect of the tested
nanotubes might be due to frustrated phagocytosis followed
by chronic inflammation, which has been described for
asbestos fibers [33,34] and for MWCNTs as well [35]. An
exaggerated inflammatory response of the peritoneal meso-
thelium with granuloma formation was observed by Poland
and co-workers [12] after injection of long but not short
amosite asbestos fibers and also after injection of MWCNTs
with a large proportion of long fibers. Poorly soluble but
otherwise non-toxic particles that are non-digestible and
non-degradable can harm macrophages when they take up a
large volume of this material or when this material activates
and damages the macrophages due to its long fiber shape.
These macrophages will no longer be able to move properly
and eliminate the foreign material. Activated and apoptotic
macrophages and interaction of the foreign material with
Figure 7 Biphasic-type malignant mesothelioma observed in the amosite asbestos group. A: H & E, low magnification of tumor tissue
found on the liver surface (10×). B: H & E, higher magnification (20×). C: H & E, high-power view (40×). D: High-power view of anti-vimentin
immunohistochemistry showing a strongly positive result (40×). E: High-power view of anti-pan-cytokeratin immunohistochemistry showing positive
staining of many cells (40×). F: High-power view of anti-podoplanin immunohistochemistry revealing positivity in distinct parts of the tumor.
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that becomes chronic because of the continuing irritant
and damaging effect of the foreign material. This particle-
induced chronic inflammation and the high concentration
of reactive oxygen and nitrogen species generated in the
course of the inflammatory process can also lead to oxida-
tive damage and genotoxic effects. A significant increase in
reactive oxygen species was measured in monocyte-derived
macrophage monocultures after administration of surfac-
tant pre-coated MWCNTs, whereas uncoated MWCNTs
caused only a minor reaction [36]. In our study, the carbon
nanotubes tested were suspended in a fluid [17] contain-
ing 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC),
a major component of surfactant. We used this fluid for
dispersion, because it prevented agglomeration of the
MWCNTs during dosing of the animals. The surface of
the nanotubes in our study was otherwise free of chemi-
cals and unloaded, so that they were hydrophobic. Func-
tionalization of carbon nanotubes affects their bioactivityand changes surface reactivity, surface loading, stability,
dispersability, and agglomeration [37]. A short-term
in-vivo test [38] demonstrated a different behavior of
functionalized MWCNTs, interpreted as an influence on
nanotube size and agglomeration. Our non-functionalized
hydrophobic MWCNTs dispersed well in the DPPC-
containing medium, avoiding aggregation of nanotubes.
Aggregated nanotubes would have produced a different
reaction because of the resulting change in bioavailability,
width, length, surface area, shape, and other factors. The
hydrophobicity of carbon nanotubes enables them to pene-
trate cell membranes quite easily. Penetration of uncoated
MWCNTs with a diameter of 49 nm and a length of 3.86 μm
into lung epithelial cells has been demonstrated [39].
Furthermore, uncontrolled cell proliferation may be
the result of CNT interaction with the mitotic spindle
apparatus, which has been described in vitro for asbestos
fibers [40], for 1- to 4-nm-thin single-walled CNTs [41],
and for 10- to 20-nm-thin MWCNT fibers [42]. The
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in an increase in cells in the proliferation phase. The
MWCNTs in our study were more than twice the diam-
eter of the nanotubes used by Siegrist and co-workers
[42], therefore, interaction with the mitotic spindle cell
apparatus may be less likely.
The results of our study are in contrast to the findings
by Varga and Szendi [43], who found induction of granu-
lomas but not mesotheliomas in Fischer 344 rats. They
used single-walled CNTs with a diameter of less than
2 nm and lengths of 4 to 15 μm and short multi-walled
CNTs with diameters of 10 to 30 nm and lengths of 1 to
2 μm. Furthermore, their experimental time was only one
year. Their negative finding in respect of tumors after
treatment with MWCNTs may be due to the short nano-
tube length of only 1 to 2 μm. At least, the carcinogenic
potential of mineral fibers with a length below 5 μm was
questioned. The single-walled CNTs were less than 2 nm
in diameter, leading presumably to a curled shape getting
tangled, resulting in the occurrence of almost no single
CNT but rather a particle-like appearance and behavior.
Another difference from our study was the mode of
administration. Varga and Szendi implanted the CNT fi-
bers, encapsulated in hard gelatin capsules, into the Kertai
fold located on the inner liver surface, probably leading to
reduced deposition of nanotubes at the serosa. In our
study, we injected the fibers directly into the abdominal
cavity, suspended in a fluid.
No mesotheliomas were observed after intraperitoneal
injection of multi-walled carbon nanotubes measuring
11 nm in diameter and with a length of most nanotubes
below 5 μm into Wistar rats [14]. Nanotubes with diame-
ters of less than 20 nm most likely have a curled shape
and are tangled, and together with the relatively short
length of most fibers this is responsible for the negative
outcome in respect of tumors. The thinnest nanotubes
used in our study, which had more than twice the width
of the nanotubes tested by Muller and co-workers [14],
showed a later onset of tumor morbidity compared with
our other MWCNTs, but the induced tumor incidence
was still quite high.
In another study, MWCNTs were injected subcutane-
ously in rasH2 mice [44]. The authors implanted the test
material, which had a mean diameter of 100 nm and a
mean length of 10 micrometers, into the subcutaneous
tissue. They evaluated the tumor outcome after 26 weeks,
but observed neither tumors nor inflammatory cells at
the injection site. There are no data in the literature
showing tumors after subcutaneous injection of mineral
fibers, except the report about mesothelioma induction
in mice by subcutaneous injection of asbestos fibers by
Roe and co-workers [45], and even for a tumor response
based on a foreign-body effect the experimental time
was too short to allow final conclusions to be drawn.Mitsui MWCNT-7 carbon nanotubes with an average
width of 100 nm and a length of 1 to 20 μm (median of
2 μm) administered by intraperitoneal injection into het-
erozygous p53 mice [13,46] and by intrascrotal injection
into Fischer 344 rats [47] caused mesotheliomas as well.
Mitsui MWCNT-7 show a needle-like straight structure,
probably due to their relatively large diameter, and this
kind of MWCNTs is structurally very similar to carcino-
genic mineral fibers. This is in accordance with our
observations on our tailor-made MWCNTs. The more
needle-like MWCNTs A and B with mean widths of 85
and 62 nm, respectively, seemed to have a stronger car-
cinogenic potency than MWCNTs of type C with a
diameter of 40 nm and a more bent structure than
MWCNTs A and B. At least the low-dose MWCNT C
group showed a slightly later onset of tumor-related
morbidity compared with MWCNTs A and B. The later
onset of tumor-related morbidity and moderate meso-
thelioma incidences in the MWCNT D groups may be
due to the same reason. In the scanning electron micros-
copy photographs this type of nanotube shows a more
curved shape compared with MWCNTs A, B, and also
C. The bent nanotube material D had the highest por-
tion of WHO fibers with a length greater than 5 μm, but
the lowest portion of WHO fibers with a length greater
than 20 μm. It is known that the carcinogenic potency
of biopersistent mineral fibers increases with growing
fiber length. Frustrated phagocytosis and long clearance
half-times in the pleural space may play a role in this
context [3].There must be other factors than length and
diameter influencing the effect of MWCNTs. The kinetic
behavior of bent MWCNTs is most probably different
from that of straight MWCNTs, which might influence
clearance half-times.
Nagai and co-workers [15] demonstrated cytotoxicity
of thin and rigid MT50a-MWCNTs with a diameter of
50 nm and a length of 5.29 μm in vitro. In contrast,
thick NT115- and NT145-MWCNTs with a diameter of
150 nm and a length of 4.88 or 4.34 μm, respectively,
and tangled NTtngl nanotubes with diameters of 2 to
20 nm and a length of 3 μm were less toxic.
The same authors observed mesotheliomas in rats after
i.p. injection of MWCNTs. The diameters of these nano-
tubes were 50, 116, and 143 nm, but their average length
was only between 4 and 5 μm. The study report provided
no information as to whether the various types of nano-
tubes used differed in shape (straight, needle-like, or rather
curved or wavy). The authors treated rats with 107 to 108
nanotubes per animal and observed the effects for one year.
The number of rats available for histopathological investi-
gations was quite different per experimental group, ranging
from 6 to 43. Incidences of mesotheliomas observed per
group were mostly quite high, reaching 80 to 100%. Nano-
tubes of 50 nm in diameter caused more tumor-bearing
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after treatment of the rats with identical number concen-
trations of nanotubes. Based on this result, the authors
suggested reduced carcinogenic potency for nanotubes
with lower diameters. No tumors were found in 6 rats
treated with tangled nanotubes with a diameter of 15 nm,
even after up to three years of observation time [48]. No
tumors were found either in 15 rats treated with the same
tangled nanotubes after one year of experimental time.
The average length of the nanotubes used in this experi-
ment was quite low, but the frequency distribution in the
lengths of the various nanotubes used showed some differ-
ences, especially in the length range of 7 to 13 μm. We
think that a major effect of the length of nanotubes on
their carcinogenic potency cannot be ruled out. Tangled
nanotubes behave like granular particles, with almost no
single nanotubes available to induce mesotheliomas.
The observations by Nagai and co-workers [15] were
in concordance with the results of our study, where all
MWCNTs with mean diameters between 37 and 85 μm
and mean lengths between 8 and 10 μm (the length
distribution within each CNT sample showed a certain
percentage of CNTs with lengths greater than 20 μm)
showed a carcinogenic effect. In our study, the more
bent but not tangled or agglomerated MWCNTs D had
a longer latency period and thus lower carcinogenic
potency in comparison with the more straight and
needle-like MWCNTs A, B, and C. The absence of
mesotheliomas after three years in rats treated with tan-
gled MWCNTs [15,48] is in line with the hypothesis that
very thin, and curled and tangled CNTs only occur as
agglomerates and their toxic effects are very similar to
the ones of biopersistent granular particles. Pauluhn and
co-workers [49] described such particle-like toxic effects
in a subchronic rat inhalation study with Baytubes®.
These nanotubes are 10 to 15 nm in diameter and 2 to
10 μm in length. They were very curled and tangled,
occurring only as agglomerates, and therefore the typical
particle-like effects in rat lungs including alveolar
macrophage overload but no fiber or single CNT-related
effects occurred. Similar observations were made by
Ma-Hock and co-workers [50], who tested Graphistrength™
MWCNTs with diameters of 10 to 15 nm and lengths of 1
to 10 μm in a short-term rat inhalation study (6 days with a
3-week post-inhalation period). These carbon nanotubes
were agglomerated in bundles and caused granuloma forma-
tion in the lungs. A carcinogenic potential of such tangled
and agglomerated nanotubes at low doses seems to be un-
likely, because phagocytosis by alveolar macrophages is
given. For the pleural cavity, Donaldson and co-workers [3]
assumed a risk of asbestos-like pathogenicity for nanotubes
that are longer than 5 μm. Longer fibers cannot negotiate
the stomata (2–12 μm) and are retained there, so that they
can interact with the mesothelium and immune cells.Nagai and co-workers [15] also performed rat genome
microarray CGH analysis of mesothelioma samples from
their MWCNT groups. In the mesothelioma samples,
whose signal intensity at the Cdkn2a/2b locus was largely
lower than −1, they found homozygous deletion of the
gene. Furthermore, they detected deletion of this gene locus
also in their asbestos-induced mesothelioma samples.
The mechanism of mesothelioma induction by the
tested MWCNTs seemed to be very similar to those trig-
gered by asbestos. A known factor contributing to tumor
induction by some mineral fibers is the presence of transi-
tion metals which may cause metal-catalyzed free radical
chain reactions, as in the case of iron and hydroxyl radical
formation via the Fenton reaction. The nanotubes applied
in our study were generated using iron or cobalt as cata-
lysts, which were incorporated into the core of the nano-
tubes. We did not detect dissolution of these metals,
however, we also cannot completely exclude that some
not measurable metal components were involved in the
toxic effects, although this seems very unlikely in our
opinion. The possibility that insoluble metals included on
the particle surface could cause an immune reaction was
discussed formerly [51]. X-ray photoelectron spectros-
copy, however, revealed no metals on the surface of the
MWCNTs used in the present study.
Since biopersistent granular dusts are not able to
induce mesotheliomas after intraperitoneal injection,
even at very high doses of 4 × 20 mg per rat i.p. [9], it is
very unlikely that the mass doses administered in the
present study, ranging from 0.05 to 3.0 mg per rat,
induced the mesotheliomas per se.
To explain the carcinogenic potential of the MWCNTs
used in our study, we would primarily point to the high
numbers of nanotubes fulfilling the criteria for WHO
fibers in combination with their lack of entanglement
and of agglomeration in the suspension, which is due to
their thickness and the resulting needle-like shape. The
rigidness of the different multi-walled carbon nanotubes
is difficult to estimate and also dependent on their thick-
ness. A nanotube length of more than 15 to 20 micro-
meters, preventing clearance from the serosal cavities
because of limited stoma size and leading to frustrated
phagocytosis and subsequent chronic inflammation,
seems to be one mechanism of mesothelioma induction,
however, it is probably not the only pathway. The mean
length of our four MWCNTs was below 12 micrometers,
which is the maximum size of stomatal openings in rats
[52], but the test material also included a certain per-
centage of nanotubes longer than 20 μm.
In 97% of the MWCNT-treated mesothelioma-bearing
rats, the diaphragm was invaded by tumor cells, whereas
the serosas of the lateral and ventral abdominal walls
were only incidentally involved. The high occurrence of
mesotheliomas at this location is most probably due to
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The suspended MWCNTs were injected into the inguinal
region, but the majority of tumor tissue was found at the
diaphragm and adjacent tissue structures. The location of in-
duced tumors can be explained by the drainage flow of peri-
toneal fluid towards stomata and subsequently into
lymphatic vessels. In rats, the majority of lymphatic stomata
are located at the diaphragm [53]. Further peritoneal
stomata are present in the omentum, mesentery, pelvic peri-
toneum, anterior abdominal wall, and liver [54]. Therefore,
larger amounts of carbon nanotubes may be transported
towards the lymphatic stomata at the diaphragm. It is
supposed that nanotubes may be transported to subme-
sothelial tissue through the peritoneal stomata. Adjacent
cuboidal mesothelial cells are connected by intercellular tight
junctions, which limit migration of macrophages or trans-
port of red blood cells, particles, or plasma proteins to the
submesothelial tissue. For the pleural cavity, stomata are
likewise the only connection to the lymphatics [55] and thus
the main path for larger particles, fibers, and nanotubes to
be eliminated by flow or after phagocytosis by migrating
macrophages [56]. The stomata consist of an outer mesothe-
lial margin and an inner lymphatic endothelial orifice [57],
with round or oval openings [56]. Specifications of the size
of lymphatic stomata in rats vary from 4.5 to 8 μm [58] to 4
to 10 μm in diameter [57]. For humans, stomata 2 to 12 μm
in diameter have been reported [3]. Their size and shape
may depend on the contractile state of the diaphragm at the
time of fixation. The stomata may function as a sieve, which
longer fibers or nanotubes may be unable to pass. Longer
nanotubes or fibers like those used in our study may accu-
mulate at this location, especially at the smaller stomata, and
can impact into the adjacent mesothelium or plug the stoma.
Very small particles or very short nanotubes may be incor-
porated with fluid into mesothelial cells by pinocytosis [57].
The primary unidirectional valves in the walls of the initial
lymphatics allow and regulate entrance of serosal fluid into
the lymphatic network preventing fluid backflow. The initial
lymphatic vessels located in the submesothelial tissue have
diameters of 1 to 10 μm [53]. The high number of longer
nanotubes used in our study might have had great impact
on the area of the diaphragmatic sieve and stomata open-
ings. The increase in intraabdominal fluid in most rats was
not only a result of increased production due to inflammatory
processes, but might also have been a result of decreased
transport capabilities of the stomata.
The peritoneal tumors observed in our study closely
resemble human malignant mesothelioma with regard to
biological behavior, histopathology, and immunohistochem-
ical features. In our study, the histological features of the
MWCNT-induced mesotheliomas and the reaction pat-
terns of the immunohistochemical markers were congruent
with those observed for amosite asbestos-induced mesothe-
liomas. The immunohistochemical results were also inaccordance with the observations by Sargent and co-
workers [59], who found serosal tumors after methylcho-
lanthrene treatment and additional MWCNT inhalation in
mice. The reaction patterns described by Blackshear and
co-workers [60] for spontaneous mesotheliomas col-
lected from Fischer rats are also in agreement with
our observations.
Spontaneous mesotheliomas in rats occur at a low
incidence. In aged Wistar rats, incidences are up to 4%
in males and 0% in females [61]. In male Fischer 344
rats, mesotheliomas most frequently are restricted to the
serosa of the tunica vaginalis, and they are rare [60]. In
our medium control group, we found one mesothelioma
(2%). Consequently, the mesotheliomas we found in the
MWCNT groups of our study at incidences ranging
from 40 to 98% must be regarded almost completely as
induced by the tested MWCNTs.
There is thus a very high probability that a variety of
multi-walled carbon nanotubes are also potent carcinogens
like asbestos for humans. Our test was designed for hazard
identification of MWCNTs, not for risk assessment. We
were able to show that the selected carbon nanotubes had
mechanistic potency to induce tumors, comparable to that
of asbestos fibers. Inhalation exposure to lower doses of
these carbon nanotubes should be performed in the future
to enable proper risk assessment. The diameter, length, and
shape of the carbon nanotubes seem to be essential param-
eters determining their carcinogenic potential.
Conclusion
Because of their special mechanical, structural, chemical,
and physical properties, carbon nanotubes have great eco-
nomic relevance and production volumes are rapidly in-
creasing. Production and processing of nanotubes and
nanotube-containing materials are occupational situations
where inhalation exposure to nanotubes may occur and a
carcinogenic risk cannot be ruled out. Likewise, the staff
of research labs handling nanotubes should also be aware
of the potential carcinogenic risk, which is comparable to
that of asbestos fibers. The question immediately arises
whether all nanotubes behave in the same way, also in
respect to their potential carcinogenic risk. A similar ques-
tion had to be answered about three decades ago: do all
mineral fibers have the same carcinogenic potential and
potency and do they pose the same risk as asbestos fibers,
which were proven to be carcinogenic in humans? All
man-made mineral fibers longer than 5 μm and thinner
than 3 μm and having a length-to-diameter ratio of at
least 3:1 have to be treated as potential human carcino-
gens, if their half-time in rat lung is similar to the half-
time of mineral fibers known to induce tumors in humans
or rats after inhalation exposure. Or, putting it the other
way round, mineral fibers with low biopersistence in rat
lung and thus a half-time below a certain number of days
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ogens. Contrary to mineral fibers which, depending on their
chemical composition, can have quite different solubility
properties in lung or alveolar macrophages, all nanotubes
are of high durability because of their composition of inor-
ganic carbon only. Besides solubility, the half-time in the
lung depends on the length of fibers or nanotubes and, in
this respect, there seems to be no difference at a first glance
between fibrous mineral or fibrous carbon particles. Based
on this consideration and because of the high durability of
carbon nanotubes, their clearance from the lung or pleural
space seems to depend mostly on their length: the longer
the carbon nanotubes, the longer their residence time in
the target organ and the stronger their toxic effect. And yet,
there may be a characteristic of carbon nanotubes that may
modify their toxic and carcinogenic potency, and according
to our preliminary data and hypothesis this could be the
shape of nanotubes. The more bent, curved, or waved the
different types of nanotubes, the lower their toxic and
carcinogenic potency seems to be. Their kinetic behavior
may be slower and cell interactions less intensive. In other
words, carbon nanotubes having a straighter and more
needle-like shape can be expected to display higher toxic
and carcinogenic potency. In addition, comparable to min-
eral fibers, it seems that the longer the nanotubes or fibers,
the stronger their toxic and carcinogenic potency. On the
other hand, at the extreme, strongly curled and tangled
carbon nanotubes that exist mostly as agglomerates are less
likely to be potential contributors to fiber-specific toxicity.
Methods
Test material
For the carcinogenicity study, we used four different tailor-
made multi-walled carbon nanotubes (see Table 2), pro-
duced by means of the chemical vapor deposition method.
The fibers differed in length and diameter, but also to some
extent in the production process in that it used diverging
carbon sources or catalysts. Because of the high tempera-
tures during synthesis (850–900°C for cyclohexane and
acetonitrile and 1100–1150°C for benzene), the carbon
nanotubes were free of organic chemical remnants on
their surfaces. Traces of the catalyst were minimal. The
MWCNT surfaces were uncharged and uncoated.
Characterization of carbon nanotubes
Measuring the defect density by Raman spectroscopy re-
vealed a ratio of the 1347/cm and 1580/cm peak of 1.0
to 1.3 for all four MWCNTs. Applying the Brunauer-
Emmet-Teller (BET) method, the specific surface area of
the different MWCNTs ranged between 52 and 60 m2/g.
X-ray photoelectron spectroscopy of the MWCNT sur-
face showed a carbon content of 94.72 to 99%. The
remaining elements consisted of nitrogen (0.0 to 1.5%)
and oxygen (1.0-4.93%), depending on the carbonsource. While the acetonitrile source resulted in the high-
est nitrogen amount (1.5%), cyclohexane and benzene
caused only very low amounts (<0.27%). The oxygen con-
tent also depended slightly on the carbon source, with
benzene causing 1.0% and cyclohexane up to 4.93%.
MWCNTs A and B had a medium length of 8.57 μm
and 9.30 μm, respectively. With 85 nm and 62 nm their
diameters were a little thicker than those of MWCNTs
C and D, which were 40 nm and 37 nm, respectively.
Differences between MWCNTs A and B are the carbon
source (A: benzene; B: cyclohexane) and the generation
method (A: sublimation method; B: aerosol method).
The catalyst for both fibers was ferrocene.
MWCNT C is a thin, long fiber (40 nm in diameter and
10.24 μm in length) produced by the aerosol method with
cyclohexane as carbon source and ferrocene as catalyst.
MWCNT D is a thin fiber of medium length (37 nm
in diameter and 7.91 μm in length). It was produced by
the aerosol method with acetonitrile as carbon source
and cobaltocene as catalyst.
Both MWCNTs C and D have nearly the same diameter,
but MWCNT C has a greater length and a much higher
proportion of WHO fibers that are longer than 20 μm.
Table 2 shows the mean diameters and mean lengths of
our tailor-made MWCNTs A, B, C, D and of the amosite
asbestos used.
Characterization of amosite asbestos
The long amosite sample used as reference material was
received from Johns Manville Corp. (Littleton, CO, USA)
on August 25, 1997.
Dispersion of nanotubes and fibers
For the intraperitoneal test, we performed dispersion of
carbon nanotubes and amosite asbestos fibers in “artifi-
cial lung medium” according to Porter and co-workers
[17]. Our dispersion medium consisted of Ca2+- and
Mg2+-free phosphate-buffered saline, pH 7.4 (Biochrom
AG, Berlin, Germany), supplemented with 5.5 mM
D-glucose, 0.6 mg/ml bovine serum albumin (Sigma-
Aldrich, Seelze, Germany), and 0.01 mg/ml 1,2-dipalmi-
toyl-sn-glycero-3-phosphocholine (Sigma-Aldrich, Seelze,
Germany). To create the suspensions we used an ultra-
sonic homogenizer (Bandelin, Sonoplus HD 2070, VS
70 T) twice for 5 minutes (90% duty cycle, amplitude of
80 μm/ss).
Successful homogenization of the suspended nanotubes
was proven by SEM. Their length and diameter distribu-
tions were measured again (see Figure 8A-E). The SEM
images shown were prepared from the suspensions of the
respective last pre-test for nanotube dispersion. From each
suspension we transferred a very small volume of fluid to
the SEM mesh. We cannot exclude that some aggregates
may be in the major parts of the suspension that were not































































































0.394 ± 1.83 0.1 28.55 0.1 0.14 1.4 - 50
Fiber types, lengths and diameters (geometric mean, GMSTD), % of WHO fibers* (length greater than 20 μm) and inner angles (to evaluate the degree of circumflexion of the different CNTs, the angle at the concave
side [inner angle] was measured between two straight lines, the first from the beginning of the circumflexion to the middle and the second from the middle to the end of the circumflexion).
*WHO fibers: length greater than 5 μm, diameter less than 3 μm, and a length-to-width ratio (aspect ratio) of at least 3:1.
#Targeted fiber number dose according to WHO guideline and TRGS 905.
##Actual fiber number dose; deviations from target values are due to inhomogeneities during successive synthesis or suspension of test items.

















Figure 8 Scanning electron microscopic photographs of carbon nanotubes and asbestos fibers in suspension. Photographs were taken
from liquid formulations of CNT in medium according to Porter (physico-chemical characterization in pre-trials). CNT agglomerates occurred
infrequently and are not visible here. A: MWCNT A (left: 10,000×, right: 30,000×). B: MWCNT B (left: 10,000×, right: 30,000×). C: MWCNT C
(left: 10,000×, right: 30,000×). D: MWCNT D (left: 10,000×, right: 30,000×). E: Long amosite asbestos (left: 2,000×, right: 7,000×).
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concentrations as used for intraperitoneal injections.
Dosing scheme
Treatment (see Table 2) consisted in a single intraperi-
toneal (i.p.) injection of the test substance in the in-
guinal region. We selected the target fiber number
concentrations of 1 × 109 and 5 × 109 WHO fibers [1]
per animal according to the EU protocol [7] and the
German guideline TRGS 905 [62] for carcinogenic, mu-
tagenic, and reproduction hazardous materials. WHO
fibers are defined as fibers with a length greater than
5 μm and a diameter less than 3 μm and a length-to-
width ratio (aspect ratio) of at least 3:1 [7]. As the test
items had to be produced successively in aliquots, devi-
ations from the initially determined values were found
due to inhomogeneities in the final test item bulks.Thus, the actual doses showed some deviation from the
targeted doses. Table 2 shows the actual mass doses per
animal. The study duration was scheduled for 24 months
after i.p. injection.
The positive control group was treated with amosite
asbestos at a ten-fold lower number concentration. We
determined this concentration for i.p. administration of
amosite asbestos based on published data showing that
1 × 108 WHO amosite asbestos fibers will cause about
50% mesothelioma-bearing rats after two years of experi-
mental time [16].
Animal experiment
The study was approved according to the German Animal
Welfare Act by the local authority at the LAVES
Niedersachsen, Hannover, Germany, No. 33.9-42502-
04-11/0507; 33.9-42502-04-11/0743.
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Han rats Crl:WI(Han), 50 for each group (Charles River
Deutschland, Sulzfeld, Germany).
All rats were housed in groups of four rats in polycarbon-
ate cages (Macrolon® type IV) on absorbent softwood bed-
ding (Lignocell BK 8–15, JRS GmbH & Co KG, Rosenberg,
Germany). Tap water (Stadtwerke Hannover, Germany)
and pelleted food (R/M-H V1534, Ssniff, Soest, Germany)
was offered ad libitum and refreshed at least once weekly.
Standard animal housing conditions comprised a temperature
of 20 ± 2°C and a 12-hour light/dark cycle.
For unequivocal animal identification, the rats were
tattooed at the ears. Animals were checked at least once
daily for clinical symptoms, morbidity, or mortality. Body
weight recordings were performed at weekly intervals.
Rats were kept for 24 months after i.p. treatment and
sacrificed at the end of the study or previously euthanized
to avoid unnecessary pain and suffering if they were found
morbid and were expected to die soon. All animals which
were humanely killed due to a bad clinical condition or
which died were included in the mortality curves.Histology
We performed complete necropsy on all animals that
were euthanized either because they were in a bad clinical
condition or because a mortality of 80% was reached in
the corresponding group, or at the end of the study.
Organs and pathologic lesions were fixed in 10% buffered
formalin for 24 hours. If subsequent trimming was not
possible due to a weekend, the tissue material was trans-
ferred to 70% ethanol for further fixation up to 48 hours.
All macroscopic lesions, pre-defined parts of diaphragm,
abdominal wall, liver, spleen, kidney, mesentery, intestine,
lung, and brain were embedded in paraffin. Three-μm-
thick sections were prepared and routinely stained with
hematoxylin-eosin.
We used a bright-field microscope for evaluation of
the slides. Tumors and pre-neoplastic lesions of the
mesothelium were classified according to the INHAND
(International Harmonization of Nomenclature and Diag-
nostic Criteria for Lesions in Rats and Mice) nomenclature
[22]. A second certified veterinary pathologist reviewed
tumors and borderline lesions.Immunohistochemical analysis
From each of the dose groups, we selected ten wax
blocks with tumor tissue for immunohistochemistry. A
selection factor was the duration of fixation, which we
tried to keep as short as possible.
For immunohistochemical detection of the chosen
markers for tumor tissue, we cut 3-μm-thick paraffin
sections from the histology wax blocks containing the
tumor material and mounted them on glass slides. Paraffinsections were then dewaxed and subject to antigen retrieval
methods validated for each of the primary antibodies.
The primary antibodies used comprised monoclonal
mouse anti-vimentin (clone V9, isotype IgG1 kappa, Dako
Denmark A/S, 2600 Glostrup, Denmark, #M 0725),
monoclonal mouse-anti-pan-cytokeratin (clone PCK-26,
Sigma-Aldrich Co. LLC, Saint Louis, Missouri 63103,
USA, #C-1801), and mouse-anti-podoplanin (clone LF3,
Novus Biologicals, Cambridge, UK, #NB110-96423).
Heat-induced antigen retrieval was performed in a
citrate-buffered solution. All slides were rinsed with Tris-
buffered saline (pH 7.6) plus 0.01% Tween®20 (Merck
KGaA, Darmstadt, Germany, 8.22184). We incubated the
slides for 20 minutes at 21°C in normal goat serum (Vector
Laboratories Inc., Burlingame, CA, USA, S-1000) and then
with the primary antibody for 1 hour at 21°C. As secondary
antibodies, we applied a biotin-SP-conjugated AffiniPure
goat-anti-mouse IgG (Jackson Immunoresearch, West
Grove, PA, USA, 111-065-100) for a 30-minute incubation
time at 21°C.
Immunostaining was done with a routine method using
alkaline phosphatase streptavidin-biotin (Vector Laborato-
ries Inc., Burlingame, CA, USA, #S-5100) and Fast Red as
chromogen (Fast Red substrate pack, BioGenex, Freemont,
CA, USA, #HK182-5 K). The slides were finally counter-
stained with Mayer’s hematoxylin (Linaris Biologische
Produkte GmbH, Wertheim-Bettingen, Germany, EGH3411).
We performed cover slipping using Aquatex® aqueous
mounting medium (Merck KGaA, Darmstadt, Germany,
#1.08562). Sample permeabilization, antibody concentra-
tions, antibody reactions, and staining procedures were
optimized for each antibody to get clear and specific
immunohistochemical signals.
Statistics
We compared the numbers of rats with and without
mesothelioma in the different dose groups with the
medium controls by the chi-squared fourfold test, chosing
a level of significance of p ≤0.05.
Abbreviations
μm: Micrometer; CNT: Carbon nanotubes; i.p: intraperitoneal; MWCNT:
Multi-walled carbon nanotube; Nm: Nanometer; SEM: Scanning electron
microscopy; SWCNT: Single-walled carbon nanotube; WHO: World Health
Organization.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SR was involved in planning the pathological investigations and tissue
sampling. She performed histopathology and immunohistochemistry of this
study and was involved in the interpretation and discussion of results. She
wrote major parts of the manuscript and provided the histological
photographs. AH performed characterization of the nanotubes in suspension.
She evaluated different suspension media to find an optimal method to
avoid agglomeration of nanotubes at the time of administration. In addition,
she was involved in the dosing of the rats. She was responsible for project
management after the death of Bernd Bellmann. OC was involved in the
Rittinghausen et al. Particle and Fibre Toxicology 2014, 11:59 Page 17 of 18
http://www.particleandfibretoxicology.com/content/11/1/59characterization of the nanotubes and their suspension. He contributed to
the chapter “Methods” and was involved in the interpretation and discussion
of results. HE reviewed the histopathological slides of tumors. He was
involved in the interpretation and discussion of results and review of the
manuscript. UH was involved in the design of the study, the interpretation
and discussion of results, and the writing of the manuscript. AL generated
the nanotubes and performed their characterization. DS was involved in
animal necropsy, photographic documentation, discussion of
histopathological slides, interpretation and discussion of results, and the
writing of the manuscript. All authors read and approved the final
manuscript.
Acknowledgments
This project received funding from the German Federal Ministry of Education
and Research, grant no: 03X0109A.
The authors are very grateful to Bernd Bellmann (†) for initiating this study.
They would like to thank C. Blum, G. Geide, M. Schleiss, A. Schulze, and K.
Serwatzki for their excellent technical assistance. The authors wish to thank
Karin Schlemminger for language correction.
Author details
1Fraunhofer Institute for Toxicology and Experimental Medicine ITEM,
Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany. 2Leibniz Institute for Solid
State and Materials Research Dresden, PF 270116, 01171 Dresden, Germany.
Received: 9 September 2014 Accepted: 28 October 2014
References
1. World Health Organisation WHO: Reference Methods for Measuring Airborne
Man-Made Mineral Fibres (MMMF), WHO/EURO MMMF Reference Scheme,
WHO Technical Committee for Monitoring and Evaluating Airborne MMMF.
Copenhagen: WHO Regional Office for Europe; 1985.
2. Miller BG, Searl A, Donaldson K, Cullen RT, Bolton RE, Buchanan D, Soutar
CA: Influence of fibre length, dissolution and biopersistence on the
production of mesothelioma in the rat peritoneal cavity. Ann Occup Hyg
1999, 43:155–166.
3. Donaldson K, Poland CA, Murphy FA, MacFarlane M, Chernova T, Schinwald
A: Pulmonary toxicity of carbon nanotubes and asbestos - similarities
and differences. Adv Drug Deliv Rev 2013, 65:2078–2086.
4. Mossman B, Light W, Wei E: Asbestos: mechanisms of toxicity and
carcinogenicity in the respiratory tract. Ann Rev Pharm Tox 1983, 23:595–615.
5. Jasani B, Gibbs A: Mesothelioma not associated with asbestos exposure.
Arch Pathol Lab Med 2012, 136:262–267.
6. Muhle H, Pott F, Bellmann B, Takenaka S, Ziem U: Inhalation and injection
experiments in rats to test the carcinogenicity of MMMF. Ann Occup Hyg
1987, 31:755–757.
7. JRC EUR 18748 EN – European Commission Joint Research Centre: II3.
Carcinogenicity of synthetic mineral fibres after intraperitoneal injection
in rats. In Methods for the determination of the hazardous properties for
human health of Man Made Mineral Fibres (MMMF). ECB/TM/18(97) rev.
Edited by Bernstein DM, Sintes JMR. Ispra, Italy: European Commission Joint
Research Centre, Institute for Health and Consumer Protection; 1999.
8. SCOEL: Recommendation from the Scientific Committee on Occupational
Exposure Limits for man-made mineral fibres (MMMF) with no indication for
carcinogenicity and not specified elsewhere. SCOEL/SUM/88 2012, 2012:1–17.
9. Pott F, Roller M, Rippe RM, German P-G, Bellmann B: Tumours by the
Intraperitoneal and Intrapleural Routes and Their Significance for the
Classification of Mineral Fibres. In Mechanisms in Fibre Carcinogenesis.
Edited by Brown RC, Hoskins JA, Johnson NF. New York: Plenum Press;
1991:547–565.
10. Hou PX, Xu ST, Ying Z, Yang QH, Liu C, Cheng HM: Hydrogen adsorption/
desorption behavior of multi-walled carbon nanotubes with different
diameters. Carbon 2003, 41:2471–2476.
11. Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexander A:
Carbon nanotubes: a review of their properties in relation to pulmonary
toxicology and workplace safety. Toxicol Sci 2006, 92:5–22.
12. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V,
Brown S, Macnee W, Donaldson K: Carbon nanotubes introduced into the
abdominal cavity of mice show asbestos-like pathogenicity in a pilot
study. Nat Nanotechnol 2008, 3:423–428.13. Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N,
Kitajima S, Kanno J: Induction of mesothelioma in p53+/− mouse by
intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci
2008, 33:105–116.
14. Muller J, Delos M, Panin N, Rabolli V, Huaux F, Lison D: Absence of
carcinogenic response to multiwall carbon nanotubes in a 2-year
bioassay in the peritoneal cavity of the rat. Toxicol Sci 2009, 110:442–448.
15. Nagai H, Okazaki Y, Chew SH, Misawa N, Yamashita Y, Akatsuka S, Ishihara T,
Yamashita K, Yoshikawa Y, Yasui H, Jiang L, Ohara H, Takahashi T, Ichihara G,
Kostarelos K, Miyata Y, Shinohara H, Toyokuni S: Diameter and rigidity of
multiwalled carbon nanotubes are critical factors in mesothelial injury
and carcinogenesis. Proc Natl Acad Sci U S A 2011, 108:E1330–E1338.
16. Davis JM, Bolton RE, Miller BG, Niver K: Mesothelioma dose response
following intraperitoneal injection of mineral fibres. Int J Exp Pathol 1991,
72:263–274.
17. Porter D, Sriram K, Wolfarth M, Jefferson A, Schwegler-Berry D, Andrew ME,
Castranova V: A biocompatible medium for nanoparticle dispersion.
Nanotoxicology 2008, 2:144–154.
18. Carthew P, Hill RJ, Edwards RE, Lee PN: Intrapleural administration of fibres
induces mesothelioma in rats in the same relative order of hazard as
occurs in man after exposure. Hum Exp Toxicol 1992, 11:530–534.
19. Rittinghausen S, Ernst H, Muhle H, Mohr U: Atypical malignant
mesotheliomas with osseous and cartilaginous differentiation after
intraperitoneal injection of various types of mineral fibres in rats.
Exp Toxicol Pathol 1992, 44:55–58.
20. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E: Histological typing
of lung and pleural tumours. World Health Organization 1999, 3:25–66.
21. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y: The new world
health organization classification of lung tumours. Eur Respir J 2001,
18:1059–1068.
22. Greaves P, Chouinard L, Ernst H, Mecklenburg L, Pruimboom-Brees IM, Rinke
M, Rittinghausen S, Thibault S, Von Erichsen J, Yoshida T: Proliferative and
non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle
and mesothelium. J Toxicol Pathol 2013, 26(3 Suppl):1S–26S.
23. Yaziji H, Battifora H, Barry TS, Hwang HC, Bacchi CE, McIntosh MW, Kussick
SJ, Gown AM: Evaluation of 12 antibodies for distinguishing epithelioid
mesothelioma from adenocarcinoma: identification of a three-antibody
immunohistochemical panel with maximal sensitivity and specificity.
Mod Pathol 2006, 19:514–523.
24. Fassina A, Cappellesso R, Guzzardo V, Dalla Via L, Piccolo S, Ventura L,
Fassan M: Epithelial-mesenchymal transition in malignant mesothelioma.
Mod Pathol 2012, 25:86–99. Epub 2011 Oct 7.
25. Marchevsky AM: Application of immunohistochemistry to the diagnosis
of malignant mesothelioma. Arch Pathol Lab Med 2008, 132:397–401.
26. Husain AN, Colby TV, Ordóñez NG, Krausz T, Borczuk A, Cagle PT, Chirieac
LR, Churg A, Galateau-Salle F, Gibbs AR, Gown AM, Hammar SP, Litzky LA,
Roggli VL, Travis WD, Wick MR: Guidelines for pathologic diagnosis of
malignant mesothelioma: a consensus statement from the international
mesothelioma interest group. Arch Pathol Lab Med 2009, 133:1317–1331.
27. Husain AN, Colby T, Ordóñez N, Krausz T, Attanoos R, Beasley MB, Borczuk
AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle
F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG,
Roggli V, Travis WD, Wick M: International mesothelioma interest group.
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012
update of the consensus statement from the international mesothelioma
interest group. Arch Pathol Lab Med 2013, 137:647–667.
28. Chirieac LR, Pinkus GS, Pinkus JL, Godleski J, Sugarbaker DJ, Corson JM: The
immunohistochemical characterization of sarcomatoid malignant
mesothelioma of the pleura. Am J Cancer Res 2011, 1:14–24. Epub 2010 Sep 30.
29. Ordóñez NG: What are the current best immunohistochemical markers
for the diagnosis of epithelioid mesothelioma? A review and update.
Hum Pathol 2007, 38:1–16. Epub 2006 Oct 23.
30. Ordóñez NG: Mesothelioma with signet-ring cell features: report of 23
cases. Mod Pathol 2013, 26:370–384. Epub 2012 Oct 5.
31. Abe S, Morita Y, Kaneko MK, Hanibuchi M, Tsujimoto Y, Goto H, Kakiuchi S,
Aono Y, Huang J, Sato S, Kishuku M, Taniguchi Y, Azuma M, Kawazoe K,
Sekido Y, Yano S, Akiyama S, Sone S, Minakuchi K, Kato Y, Nishioka Y:
A novel targeting therapy of malignant mesothelioma using
anti-podoplanin antibody. J Immunol 2013, 190:6239–6249.
32. Ohnuma-Koyama A, Yoshida T, Takahashi N, Akema S, Takeuchi-Kashimoto Y,
Kuwahara M, Nagaike M, Inui K, Nakashima N, Harada T: Malignant peritoneal
Rittinghausen et al. Particle and Fibre Toxicology 2014, 11:59 Page 18 of 18
http://www.particleandfibretoxicology.com/content/11/1/59mesothelioma with a sarcomatoid growth pattern and signet-ring-like
structure in a female F344 rat. J Toxicol Pathol 2013, 26:197–201.
33. Donaldson K, Murphy FA, Duffin R, Poland CA: Asbestos, carbon
nanotubes and the pleural mesothelium: a review of the hypothesis
regarding the role of long fibre retention in the parietal pleura,
inflammation and mesothelioma. Part Fibre Toxicol 2010, 7:5.
34. Tomatis M, Turci F, Ceschino R, Riganti C, Gazzano E, Martra G, Ghigo D,
Fubini B: High aspect ratio materials: role of surface chemistry vs. length
in the historical “long and short amosite asbestos fibers”. Inhal Toxicol
2010, 22:984–998.
35. van Berlo D, Clift MJ, Albrecht C, Schins RP: Carbon nanotubes: an insight
into the mechanisms of their potential genotoxicity. Swiss Med Wkly 2012,
142:w13698.
36. Gasser M, Wick P, Clift MJ, Blank F, Diener L, Yan B, Gehr P, Krug HF, Rothen-
Rutishauser B: Pulmonary surfactant coating of multi-walled carbon nanotubes
(MWCNTs) influences their oxidative and pro-inflammatory potential in vitro.
Part Fibre Toxicol 2012, 9:17.
37. Hamilton RF Jr, Wu Z, Mitra S, Shaw PK, Holian A: Effect of MWCNT size,
carboxylation, and purification on in vitro and in vivo toxicity,
inflammation and lung pathology. Part Fibre Toxicol 2013, 10:57.
38. Ali-Boucetta H, Nunes A, Sainz R, Herrero MA, Tian B, Prato M, Bianco A,
Kostarelos K: Asbestos-like pathogenicity of long carbon nanotubes
alleviated by chemical functionalization. Angew Chem Int Ed 2013,
52:2274–2278.
39. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Schwegler-Berry D,
Castranova V, Porter DW: Distribution and persistence of pleural penetrations
by multi-walled carbon nanotubes. Part Fibre Toxicol 2010, 7:28.
40. Huang SX, Jaurand MC, Kamp DW, Whysner J, Hei TK: Role of mutagenicity
in asbestos fiber-induced carcinogenicity and other diseases. J Toxicol
Environ Health B Crit Rev 2011, 14:179–245.
41. Sargent LM, Shvedova AA, Hubbs AF, Salisbury JL, Benkovic SA, Kashon ML,
Lowry DT, Murray AR, Kisin ER, Friend S, McKinstry KT, Battelli L, Reynolds
SH: Induction of aneuploidy by single-walled carbon nanotubes. Environ
Mol Mutagen 2009, 50:708–717.
42. Siegrist KJ, Reynolds SH, Kashon ML, Lowry DT, Dong C, Hubbs AF, Young
SH, Salisbury JL, Porter DW, Benkovic SA, McCawley M, Keane MJ, Mastovich
JT, Bunker KL, Cena LG, Sparrow MC, Sturgeon JL, Dinu CZ, Sargent LM:
Genotoxicity of multi-walled carbon nanotubes at occupationally
relevant doses. Part Fibre Toxicol 2014, 11:6.
43. Varga C, Szendi K: Carbon nanotubes induce granulomas but not
mesotheliomas. In Vivo 2010, 24:153–156.
44. Takanashi S, Hara K, Aoki K, Usui Y, Shimizu M, Haniu H, Ogihara N, Ishigaki
N, Nakamura K, Okamoto M, Kobayashi S, Kato H, Sano K, Nishimura N,
Tsutsumi H, Machida K, Saito N: Carcinogenicity evaluation for the
application of carbon nanotubes as biomaterials in rasH2 mice. Sci Rep
2012, 2:498. Erratum in: Sci Rep 2013, 3:1688.
45. Roe FJ, Carter RL, Walters MA, Harington JS: The pathological effects of
subcutaneous injections of asbestos fibres in mice: migration of fibres to
submesothelial tissues and induction of mesotheliomata. Int J Cancer
1967, 2:628–638.
46. Takagi A, Hirose A, Futakuchi M, Tsuda H, Kanno J: Dose-dependent
mesothelioma induction by intraperitoneal administration of multi-wall
carbon nanotubes in p53 heterozygous mice. Cancer Sci 2012, 103:1440–1444.
47. Sakamoto Y, Nakae D, Fukumori N, Tayama K, Maekawa A, Imai K, Hirose A,
Nishimura T, Ohashi N, Ogata A: Induction of mesothelioma by a single
intrascrotal administration of multi-wall carbon nanotube in intact male
Fischer 344 rats. J Toxicol Sci 2009, 34:65–76.
48. Nagai H, Okazaki Y, Chew SH, Misawa N, Miyata Y, Shinohara H, Toyokuni S:
Intraperitoneal administration of tangled multiwalled carbon nanotubes
of 15 nm in diameter does not induce mesothelial carcinogenesis in
rats. Pathol Int 2013, 63:457–462.
49. Pauluhn J: Multi-walled carbon nanotubes (Baytubes): approach for
derivation of occupational exposure limit. Regul Toxicol Pharmacol 2010,
57:78–89.
50. Ma-Hock L, Strauss V, Treumann S, Küttler K, Wohlleben W, Hofmann T, Gröters
S, Wiench K, van Ravenzwaay B, Landsiedel R: Comparative inhalation toxicity
of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low
surface carbon black. Part Fibre Toxicol 2013, 10:1–19.
51. Hubbs AF, Mercer RR, Benkovic SA, Harkema J, Sriram K, Schwegler-Berry D,
Goravanahally MP, Nurkiewicz TR, Castranova V, Sargent LM: Nanotoxicology–a
pathologist’s perspective. Toxicol Pathol 2011, 39:301–324. Epub 2010 Dec 14.52. Schinwald A, Murphy FA, Prina-Mello A, Poland CA, Byrne F, Movia D, Glass
JR, Dickerson JC, Schultz DA, Jeffree CE, Macnee W, Donaldson K: The
threshold length for fiber-induced acute pleural inflammation: shedding
light on the early events in asbestos-induced mesothelioma. Toxicol Sci
2012, 128:461–470.
53. Grimaldi A, Moriondo A, Sciacca L, Guidali ML, Tettamanti G, Negrini D:
Functional arrangement of rat diaphragmatic initial lymphatic network.
Am J Physiol Heart Circ Physiol 2006, 291:H876–H885.
54. Michailova K, Wassilev W, Wedel T: Scanning and transmission electron
microscopic study of visceral and parietal peritoneal regions in the rat.
Ann Anat 1999, 181:253–260.
55. Li YY, Li JC: Ultrastructural study of pleural lymphatic drainage unit and
effect of nitric oxide on the drainage capacity of pleural lymphatic
stomata in the rat. Ann Anat 2004, 186:25–31.
56. Wang ZB, Li M, Li JC: Recent advances in the research of lymphatic
stomata. Anat Rec (Hoboken) 2010, 293:754–761.
57. Abu-Hijleh MF, Habbal OA, Moqattash ST: The role of the diaphragm in
lymphatic absorption from the peritoneal cavity. J Anat 1995,
186(Pt 3):453–467.
58. Azzali G: The transendothelial passage in the absorbing peripheral
lymphatic vessel of the rodent diaphragm. Ital J Anat Embryol 1995,
100(Suppl 1):287–298.
59. Sargent LM, Porter DW, Staska LM, Hubbs AF, Lowry DT, Battelli L, Siegrist
KJ, Kashon ML, Mercer RR, Bauer AK, Chen BT, Salisbury JL, Frazer D,
McKinney W, Andrew M, Tsuruoka S, Endo M, Fluharty KL, Castranova V,
Reynolds SH: Promotion of lung adenocarcinoma following inhalation
exposure to multi-walled carbon nanotubes. Part Fibre Toxicol 2014, 11:3.
60. Blackshear PE, Pandiri AR, Ton TV, Clayton NP, Shockley KR, Peddada SD,
Gerrish KE, Sills RC, Hoenerhoff MJ: Spontaneous mesotheliomas in F344/N
rats are characterized by dysregulation of cellular growth and immune
function pathways. Toxicol Pathol 2013, 42:863–876.
61. National Toxicology Program: NTP Historical controls report. All routes
and vehicles. Wistar Han rats. June 2013. US Department of Health and
Human Services; 2013 [http://ntp.niehs.nih.gov/ntp/historical_controls/
ntp2000_2013/histcont2013_whanrats_allroutes_508.pdf]
62. TRGS 905: Technical rules for hazardous substances 905. Technical Rules
(TRGS) established by the Committee on Hazardous Substances (AGS).
Verzeichnis krebserzeugender, erbgutverändernder oder
fortpflanzungsgefährdender Stoffe. German Federal Institute for
Occupational Safety and Health (BAuA) 2014, 24:3–4.
doi:10.1186/s12989-014-0059-z
Cite this article as: Rittinghausen et al.: The carcinogenic effect of
various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal
injection in rats. Particle and Fibre Toxicology 2014 11:59.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
